Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts


About Conference

Conference Series is delighted to invite you to attend the International Pediatrics, Infectious Diseases and Healthcare Conference 2019, which is to be held at Paris, France dated October 16-17, 2019. Pediatrics 2019 will be an ingenious and invigorating International conference reflecting the direction of Pediatrics in the 21st century in a secure yet exciting environment that offers a wide range of diversions to participants of all backgrounds. This conference provides an excellent opportunity to discuss the latest developments within the field.

Pediatrics 2019 highlighting the theme “Cognizance into an Unexplored Areas of Pediatrics” provides an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking.

Pediatrics 2019 will focus on the latest and exciting innovations in all areas of research, offering a unique opportunity for Pediatricians across the globe to meet, network, and perceive new scientific interventions. The concept of this congress and program was developed for Pediatricians’ working in Primary and Secondary Care, as well as for specialists in the diverse areas of Pediatrics, Infectious Diseases, Pediatric Surgeons, Family Medicine Doctors, General Practitioners, Nurse Practitioners, Researchers and Policy Makers.

We also welcomes the participation of Presidents, CEO’s, Delegates and industrial executives from Pharma and Health care sectors making the congress a perfect platform to network, share views and knowledge through interactive keynote, plenary, poster and B2B discussions.

Why to attend?

Pediatrics 2019 is an international platform for presenting research about diagnosis, prevention and management and exchanging ideas about it and thus, contributes to the dissemination of knowledge in Pediatrics and child health for the benefit of both the academia and business.

The organizing committee of this Pediatric meeting is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at Pediatrics 2019, where you will be sure to have a meaningful experience with scholars from all around the world. All members of the Pediatrics'19, organizing committee look forward to meet you in Paris, France.

Targeted audience:

  • Pediatrician
  • Infectious Disease Specialist
  • Cardiologists
  • Gastro-enterologists
  • Pulmunologists
  • Surgeons
  • Pediatric Infectious Diseases Specialist
  • Researchers
  • Immunologists
  • Bacteriologists
  • Pathologists
  • Oncologists
  • Neonatologists
  • Nurses
  • Associations and societies
  • Pediatric faculty
  • Medical colleges
  • Data management companies
  • Pediatric physicians
  • Obstetricians
  • Training institutes
  • Manufacturing medical device companies
  • Case managers
  • Young researchers
  • Physician assistants
  • Hospital administrators
  • Hospital general counsel


Sessions and Tracks

Track 1: Pediatrics

Pediatrics is the field of medicine that is concerned about the well-being of neonatal, children, and adults. It also concerns on their development and advancement and their chance to accomplish maximum capacity as grown-ups. The Pediatric academy of America, prescribes that the children should be under pediatric care, up to the age of 21. The point of investigation of pediatrics is to decline the death rate of children and newborns, to control the spread of infectious diseases, for a long ailment free life.

Track 2: Infectious Diseases

Infectious diseases, which annually claim about 14 million lives i.e. 25% of the more or less 56 million deaths recorded worldwide. The recent trends of pediatrics have achieved exceptional advances in reductions in childhood mortality. The global challenge of preventing HBV in children has shown that the deadliest infectious diseases can be prevented by acquiring proper awareness.

Track 3: Pediatric Immunology

Pediatric immunology plays a prominent role in interpreting the cell and molecular mechanisms underlying the immune system and it has seriously intruded within the development of new diagnosis and treatment. A study of Immunological innovations has revealed that, respiratory panel polymerase chain reaction (PCR) testing shows negativity in case of presence of infection. This shows that immunological techniques of current trends are not widely available. Diagnosis for bronchiolitis and influenza is widely available nowadays. While for human rhinovirus, adenovirus, Para influenza, and/or human Meta pneumovirus is not readily available due to cost prohibitive. Immunogenic techniques are being advanced and updated due to the rise of resistant pathogens infecting children. A study suggests that Human Boca virus (HBoV) is the most recent respiratory virus which is difficult to diagnose. The journal of the Pediatric Infectious Diseases Society states that staphylococcus aureus strains are methicillin-resistant.

Track 4: Nanotechnology in Pediatrics

One of the emerging technologies recently is, Nanotechnology. The stream is very effective because it aims with target drug delivery. Nanotechnology is the manipulation of material on an atomic and molecular scale, by changing its physical, chemical and biological properties to produce novel materials, devices, and systems. Immunological techniques use nanotechnology to improve the health of the patients because of its biocompatibility. Nanoparticles can have cytotoxic, genotoxic, and inflammatory effects in mammalian cells, and can induce oxidative stress response, which should be considered before selection of Nano technological approach. The most important things are,

  • High surface area

  • Intrinsic toxicity

Recent study suggests that iron oxide nanoparticles were found in large variety of organism and they have collected response due to their super paramagnetic properties. The current study suggests that biofilm associated diseases are difficult to treat and hence the field of medicine uses Nanomaterial and Nanostructure

Track 5: Pediatric Pharmacology

 Age-adapted drug formulations are a challenge in drug development. In formulating medications for pediatric, manufacturers must concentrate on dysphagia, dosing and physiological changes. The fact is that many of the pediatric medicines are scaled-down geriatric medicines. In infants and adults, the immaturity of the enzyme may determine the pharmacokinetics of the excipients. A study suggests that wrong medications might lead to adverse drug effectsA survey shows that hospitalization due to adverse effects is 4times higher in infants when compared with adults.

Track 6: Perinatal HIV and Breast Feeding

This section intends to provide potential risk associated with breast feeding in HIV infected women. Mothers infected with Human Immunodeficiency Virus (HIV) can transmit the virus to their babies in utero, intrapartum or postpartum through breastfeeding. With response to community, edits were continued to integrate people’s language which focuses on person, rather than the diseases, says the survey. Mother-to-child HIV transmission reported that 2.1 million children living with HIV and 430,000 new HIV infections in infants occurring every year due to breast feeding. Hence efforts were made by making breastfeeding safer by using antiretroviral prophylaxis to either mothers or their infants.

Advances were made in the field of perinatal HIV by providing an elvitegravir/cobicistat regimen as a therapeutic drug in deducing the viral load and therapeutics like intrapartum intravenous (IV) zidovudine as it is very effective in reducing the risk of transmission of HIV, the recent trend suggests that, a single dose of oral nevirapine to mothers during labor and to neonates would further reduce transmission of HIV. The United Nations recommendation states that the replacement feeding can be a avoidance of all breastfeeding by HIV-infected mothers. Otherwise, exclusive breast-feeding is recommended during the first months of life and should then be discontinued as soon as it is feasible.

Track 7: Pediatric Healthcare and Nutrition

The world of  nutrition and healthcare is constantly changing, as new technologies emerge. Nutritional requirements differ for children when compared with adults, as they are in their growing age they need balanced nutrition. In the prenatal period, infant’s growth totally depends on maternal nutrition. They need for calories, especially in the form of protein, are greater than at any postnatal period because of rapid increase in both height and weight. Breastfeeding to age 2 years with appropriate complementary feeding after 6 months contributes to good nutrition, a study suggests.

The trends in nutrition recommended Paleo diet for children as it is rich in high-protein, high-fiber diet consisting of lean meat, fish, fruits, veggies, eggs and oil and it is a gluten free diet. Since pediatric nutrition concerns the mother, the pediatric nutrition market is emerging globally at a significant pace.  The Asian market is contributing significantly one-third of the world’s pediatric nutrition. The role of the nurse is to educate and give nutritional guidance for good eating habits. A special problem is overfeeding in the early childhood years, which may lead to several diseases.

Track 8: Onco-pedic Effects and Approaches

With the increased population of children diagnosed with cancer, technology makes changes in pediatric oncology nursing care, treatment and prognosis. The incidence of cancer in childhood is increasing abruptly. It is estimated that the incidence of childhood cancer is increasing by 0.6% per year.

Advances in the treatment of childhood cancer have shown an improvement in prognosis in recent years. Therefore, survivor rate of children with cancer is going to rise in the past decade. The recent trends in the treatment of pediatric oncology says that radiolabeled 131-I-MIBG selectively targets radiation to catecholamine-producing Neuroblastoma cells. Monoclonal antibodies play a vital role in the treatment of cancer in the field of onco-ped. They are designed to potentiate chemotherapy, particularly in the setting of relapsed leukemia. Four out of five children diagnosed with cancer can be cured with contemporary cancer therapy. Only a small percentage of childhood cancers, are due to familial or genetic factors and an even smaller percentage of childhood cancer has an identified environmental link.

Track 9: Obesogenic Factors and Recent Innovations

According to public health England, quarter of children between the age group of 2 – 10 years old are overweight or obese around the globe and by 2034, 70 per cent of adults are expected to be obese. Children who are obese are at greater risk for high blood pressure, type 2 diabetes and heart disease and the study also suggests that Obesity rates are higher among Blacks and Latinos than among Whites and Asian Americans. The recent innovations in pediatric obesity says that Percent overweight (%OW) is helpful for providing evidence of weight change in severely obese children and recent treatment involves Lifestyle intervention which modifies children’s daily dietary and activity behaviors, targeting sustainable changes associated with healthy weight management. Pharmacotherapy is an emerging trend in the treatment of obesity in children but facing with side effects is the only cons it has.

Track 10: Challenging Tropical Diseases in Children

The neglected tropical diseases (NTDs) of around 17 or more parasitic diseases and its related infections represent the most common illness. Population growth, urbanization, deficiencies in water and sanitation systems lead to re- emergence of tropical diseases says the study. Cases of Neuro-schistosomiasis, Neurocysticercosis, and Chagasic stroke are increasingly detected in western countries. Recently, Chikungunya virus adapted to Aedus albopictus is spread in Europe has been reported. Dengue fever is the second most common mosquito-borne disease after malaria, and every year more than 50 million cases of dengue fever resulting in 25,000 fatalities.

The pipelines for new drugs for these diseases have been dried for the past 3decades due to the absence of commercial market. Recently, Metallo-β-lactamase has been isolated from Klebsiella pneumoniae, offering few treatment opportunities. Several vaccines, including vaccines against hookworm infection, schistosomiasis and leishmaniasis are in phase 1 and phase 2 clinical trials for product development. These would be used as “vaccine-linked chemotherapy” alongside drugs in a comprehensive treatment.

Track 11: Pediatric Metabolic Disorder- Recent Epidemics

Metabolism is carried out by chemical substances called enzymes, which are made by cells in the body. If a genetic abnormality affects the function of an enzyme or causes it to be deficient or missing altogether, various metabolic disorders can occur. Metabolic disorders are classified by the particular building block that is affected. These disorders usually result from an,

  • Inability to break down a substance that should be broken down, allowing a toxic intermediate substance to build up
  • Inability to produce some essential substance

The recent epidemics of metabolic diseases cannot be attributed only to genetic background and changes in diet, exercise and aging. Metabolic diseases have their origins during development due to altered programming that increases susceptibility to disease later in life. Metabolism disruptors are endocrine disruptors that increase the susceptibility to metabolic diseases. Some metabolism disruptors may cause metabolic diseases pursue while others act via increasing the sensitivity or set point for disease. The metabolic disruptor hypothesis provides a focus on preventing metabolic diseases.

Track 12: Recent Advances in Pediatric Interventional Cardiology

For the past 10 years, there have been vast technological achievements in Pediatric interventional cardiologyIn addition to that, there have been several advances in cardiac imaging, especially in 3-dimensional imaging of echocardiography, computed tomography, magnetic resonance imaging, and cine-angiography. Some advancement that reflect mainly on adult population, such as patent foramen ovale device closure and closure of post infarct ventricular septal defects aimed solution for Pediatric Cardiology. Therefore, more types of congenital heart diseases can be treated in the cardiac catheter laboratory today than ever before. As a result of recent technological advances, more types of CHDs than ever before are now possible to treat in the cardiac catheter laboratory. Furthermore, lesions previously considered resistant to interventional therapies can now be managed with high success rates. However, most current recommendations for interventional procedures refer to off-label use of devices. Nevertheless, the Pediatric interventional cardiology community has made attempts to develop better solutions to minimize the need for open heart surgery and optimize overall outcomes.

Track 13: Fungal and Bacterial Infections: Head to Toe

Children are prone to various infections. No matter how clean the environment is, the inherent nature of germs, tend to attract bacteria and other microbes. When babies are born, they come with a completely sterile digestive system and the immune system has not been activated. By preventing fungal infections, we ensure child’s wellbeing. The prevalence of fungal and bacterial infections is increasing, representing an enormous challenge to healthcare professionals. This increase is directly related to the growing population of immunocompromised individuals especially children with the use of intensive chemotherapy and immunosuppressive drugs.

Bacteria have been recognized as a cause of serious infection with increased frequency during the past 2 decades. Virtually not all fungi are pathogenic, and their infection is opportunistic. Opportunistic fungal infections cause diseases exclusively in immune-compromised individuals. Recent study has been reported that, the fungal infections in babies and infants, if left untreated, are dangerous and can even lead to death due to compromised immune systems and weakening inflammatory response. The current trend in treating bacterial and fungal infection is Soy, a hormone disruptor. About 75% of the U.S. soy crop is now genetically engineered.

Track 14: Neonatal and Congenital Infections

Newborn congenital infections have a variety of causes fluctuate from pregnancy to genetic malformations in utero. In many cases, however, a congenital anomaly may have no known cause. For e.g. the structural defect such as spina bifida is obvious at birth, whereas hemophilia a functional defect (a bleeding disorder) is not usually obvious until infancy or childhood. An estimation of about 270 000 deaths during the first 28 days of life were reported due to congenital anomalies globally.

Advanced interventions of the neonatal infection risk have further led to identification of several promising potential biomarkers that may translate to improved diagnosis, treatment, and prognosis of neonatal sepsis in the future. Very low birth weight is an important factor for neonatal infection. Microbial agents can be transmitted from the mother to the fetus either Trans placentally, haematogenously, or via the birth canal. Microbial agents may penetrate the placental barrier and contaminate the fetus, often leading with neonatal infections. Recent studies revealed that emerging pathogens are predominantly Gram positive, of which coagulase-negative staphylococci are the commonest organisms accounting for 45–75% of all late-onset bloodstream infections.

Track 15: Pediatric Nursing and Surgery

The advanced practice nurse (APN) functions in pediatric surgery in a variety of ways. Changes in the standard of care for pediatric patients are not something the medical community takes lightly. However, there is an exception when developing clinical care guidelines for use with the pediatric patient. The recent interventions in the field of pediatric nursing paves way for the use of a machine to take over the work of the lungs, and sometimes the heart, as a rescue therapy—has given patients a second chance at life over the last 25 years and smart pills include a tiny sensor, when ingested, transmit a signal to a patch the patient wears.

The greatest intervention in the field of pediatric surgery is that the stem cells-have the potential to turn into anything—a skin cell, a liver cell, a brain cell. And stem cell transplants have the power to treat a wide range of diseases in children, from cancers like Leukemia, Lymphoma and Neuroblastoma to blood disorders, immune system diseases and bone marrow syndromes. The recent trends have reported that the chemical named sildenafil citric (the same chemical as Viagra) to reverse pulmonary hypertension.

Track 16: Healthcare Intervention- Pediatric Yoga Therapy 

Yoga is a mind-body practice that originated in India at least 2000 years ago. It is recognized by the National Institutes of Health (NIH) National Centre for Complementary and Alternative Medicine (NCCAM) as a form of CAM in the category of “mind-body” medicine. NCCAM asserts that mind-body medicine focuses on the interactions among the brain, mind, body, and behaviour, and on the powerful ways in which emotional, mental, social, spiritual, and behavioural factors can directly affect health.

Thirty four controlled studies were identified published from 1979 to 2008, with 19 RCTS and 15 NRCTs. Clinical areas for which yoga has been studied include physical fitness, cardio-respiratory effects, motor skills/strength, mental health and psychological disorders, behaviour and development, irritable bowel syndrome, and birth outcomes following prenatal yoga. There is also a progressive trend toward use of yoga as a mind-body complementary and alternative medicine intervention to improve specific physical and mental health conditions. To provide clinicians with therapeutically useful information about yoga, the evidence evaluating yoga as an effective intervention for children with health problems is reviewed. Yoga appears promising as a complementary therapy for children.

Market Analysis

Pediatrics, Infectious Diseases and Healthcare is nonpareil and open platform to explore and gain the knowledge in the field of Medical Science. This conference brings together Pediatricians, Microbiologists, Pathologists, Immunologists, Neonatologists, Bacteriologists, Virologists, Professors, Oncologists, Nutrionists, Researchers, Scientists, Students in all the areas of Medical sciences, Pharmaceutical, Life sciences, Medical associations and societies, to enable an international forum to explore the approved research. ConferenceSeries Ltd is delight to invite you all to attend and register for the “International Pediatrics, Infectious Diseases and Healthcare Conference” scheduled for October 16-17, 2019 at Paris, France.

The Organizing Committee is gearing up for an exciting and factual conference program which includes plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs all over the world. We invite you to join us at the Pediatrics 2019, where you will be sure to have a meaningful experience with scholars from around the world. All members of the International Pediatrics, Infectious Diseases and Healthcare Conference organizing committee look forward to meet you at Paris, France

Scope and Importance:

Pediatrics 2019, deals exclusively with the Pediatrical Branches, Infectious Diseases, Interventions, Treatment and Healthcare involving children. It may be surprising for the lay public and even medical fraternity that the emerging disease, its treatment and diagnosis is now getting strenuous.  About 8 new-born, out of one thousand live births will have one form of infectious diseases or other, ranging from minor to very complex ones. This would automatically entail fairly bulky health care burden. However it is a paradox that even the best educated are tuned to recognizing the existence of maladies as those afflicting predominantly the pediatric population. Both the public and private hospitals are readily catering to pediatric diseases, which albeit being very justifiable sometimes borders on to lucrative economic equations. Though Pediatrics 2019 has been one of the first outbreaks to be evolved in pediatrics, it aims at various informative and fruitful things to be delivered to the participants.

Pediatricians are expected to grow from nearly $23.8 billion in 2018 to roughly $55.1 billion by 2021, with a compound annual growth rate (CAGR) of 18.3% for the period of 2018-2021.

Global Infection Rate:

Pneumonia accounted for approximately 16% of the 5.6 million under-five deaths, killing around 880,000 children in 2016. Most of its victims were less than 2 years old. Diarrhea is a leading killer of children, accounting for approximately over 1,300 young children dying each day, or about 480,000 children a year, despite the availability of simple effective treatment. Tuberculosis (TB) is one of the world’s deadliest diseases: One fourth of the world’s population is infected with TB. In 2016, 1.4 million children around the world became sick with TB disease.

Big countries like Brazil and China reduced their child mortality rates due to infectious diseases to 10-fold over the last 4 decades. Other countries – especially in Africa – still have high child mortality rates, but it’s not true that these countries are not making progress. In Sub-Saharan Africa, child mortality has been continuously falling for the last 50 years (1 in 4 children died in the early 60s – today it is less than 1 in 10).

Over the last decade this improvement has been happening faster than ever before. Rising prosperity, rising education and the spread of health care around the globe are the major drivers of this progress. A media that would report global development could have had the headline “The number of children dying globally fell by 455 since yesterday” and they wouldn’t have this headline once but every single day over these more than 2 decades.

The most spreading infectious diseases are one of the first causes for the child maladies and mortalities. These diseases are in terms infectious and deadliest among children and infants if left untreated. Though vaccinations, treatments are available for these types of diseases, if not treated earlier causes death.

Why Paris, France?

Paris, France's capital is a major European city and a global center for art, fashion, gastronomy and culture. Its cityscape is crisscrossed by wide boulevards and the River Seine. Beyond such landmarks as the Eiffel Tower and Gothic Notre-Dame cathedral, the city is known for its cafe culture and designer boutiques along the Rue du Faubourg Saint-Honoré.

The Pediatric Practice in France is as always unique as itself. While U.S. medical school graduates had an average debt of $154,000, French medical students receive their training virtually for free. For example, first-year medical students at the Faculte de Medecine Pierre et Marie Curie in Paris have only one mandatory cost for this year: an enrollment fee of $264.

Universities and Colleges Related to the Conference:

  • Universite Sorbonne Paris Cite-USPC
  • Universite Paris Saclay
  • Universite de Lyon
  • University of Aix-Marseille
  • Communaute d'Universites et Etablissements d'Aquitaine
  • University of Lorraine
  • PSL Research University Paris
  • Languedoc-Roussillon Universites
  • Universite Paris-Est
  • Universite Lille-Nord-de-France
  • University of Strasbourg
  • Universite Federale Toulouse Midi-Pyrenees
  • Communaute Universite Grenoble Alpes
  • Universite Nice Sophia Antipolis
  • University of Nantes
  • Universite Toulouse III - Paul Sabatier

Associations and Societies:

Europe Associations:

French Society of Pediatrics; European Academy of Paediatrics; European Society of Pediatric and Neonatal Intensive Care; European Society for Pediatric Research; International Pediatric Sleep Association; European Paediatric Neurology Society; European Society for Paediatric Endocrinology; European Society of Clinical Microbiology and Infectious Diseases; European Society for Pediatric Infectious Diseases; International Union Against Tuberculosis and Lung Disease

Middle East  & Asia- Pacific Associations:

The Union of Middle-Eastern and Mediterranean Pediatric Societies; Palestine Pediatric Society; Asian Association of Paediatric Surgeons; Pediatric club; Indian Academy of Pediatrics; Middle East Pediatric Orthopedic Society; Asia-Pacific Pediatric Association; Australasian Society for Infectious Diseases; Chinese Society for Immunology; International Society for Infectious Diseases; Asia Pacific Society of Infection Control;  Pediatric Infectious Disease Society of Thailand; Infection Control Association; The Japanese Association for Infectious Diseases


American Academy of Pediatrics; American College of Pediatricians; Academic Pediatric Association; American Pediatric Surgical Association; American Academy of Child and Adolescent Psychiatry; American Society for Microbiology; Centers for Disease Control and Prevention; Infectious Diseases Society of America;

Hospitals Related to the Conference:

  • Hôpital Americain de Paris
  • Hôpital Bichat Claude
  • Hôpital Hôtel-Dieu
  • Hôpital de la Pitié-Salpetrière
  • Hôpital Necker-Enfants Malades
  • Hôpital Européen Georges-Pompidou
  • Hopital de Cannes/Centre Hospitalier de Cannes
  • Hôpital Saint-Louis
  • Hôpital Saint-Antoine
  • Hospital Center Saint Joseph-Saint Luc
  • Hôpital Arnaud-de-Villeneuve
  • Centre Hospitalier Universitaire de Rennes


Related Conferences:

11th Euro-Global Conference on Infectious Diseases, September 23-24, 2019, London, UK; 2nd World Pediatric Infectious Disease Congress, November 06-07, 2019, Paris, France; 5th World Congress on Pediatric Disease, Care & Management, November 18-19, 2019 Berlin, Germany; 7th Annual Conference on Parasitology & Infectious Diseases, November 18-19, 2019 Johannesburg, South Africa; 2nd European Pathology and Infectious Disease Conference, November 25-26, 2019 Helsinki, Finland; 21st International Conference on Pediatrics and Nursing Care, December 02-03, 2019 New York, USA

Tourists Attractions in Paris, France:

  • Eiffel Tower
  • Notre Dame Cathedral
  • Louvre Museum
  • Champs Elysées / Arc of Triumph
  • Cruise on the Seine
  • Montmartre
  • Palace of Versailles
  • The Latin Quarter - Luxembourg park
  • Moulin Rouge
  • Disneyland Paris
  • Parc des Buttes-Chaumont
  • Place de Bastille
  • Luxembourg Gardens
  • Musical Concerts at Sainte-Chapel

Past Conference Report

Pediatric Conference 2018

We would like to thank all of our wonderful and eminent speakers, conference attendees who shared their research knowledge and made Pediatric Conference 2018 as memorable and our best event ever!

International Pediatrics, Infectious Diseases and Healthcare Conference, hosted by the Conference Series LLC LTD held during November 22-24, 2018 at Cape Town, South Africa in Hotel Protea Fire and Ice by Marriot with the theme “Cognizance into Unexplored Areas of Pediatrics”. Benevolent response and active participation was received from the Editorial Board Members of Conference Series Journals as well as from the Pediatric Nurses, Doctors, Pediatric Professors, Pharmaceutical Industries, Researchers and Students from the fields of Pediatric Conference 2018, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Pediatrics and Infectious Diseases
  • Pediatric Healthcare and Nutrition
  • Pediatric Nursing and Surgery
  • Bacterial and Fungal Infections
  • Challenging Tropical Diseases in Children
  • Congenital and Neonatal Infections
  • Perinatal HIV and Breastfeeding
  • Oncopedic Effects and Approaches
  • Obesogenic  Factors and Recent Innovations
  • Pediatric Metabolic Disorders
  • Pediatric Immunology
  • Pediatric Pharmacology
  • Nanotechnology in the field of Pediatrics

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list included:


Sanjib Bhakta,

Birkbeck, University of London and UCL, UK

Fahad Alsufayan,

National Guard Health Affairs, Saudi Arabia

Martin R Evans,

American Society for Microbiology, USA

Ana Rita de Toledo Piza,

Limace Biotechnologia, Brazil

Sabine N'dri Vakou,

Institut Pasteur de Côte d'Ivoire, Côte D'Ivoire

Kelvin Ngongolo,

The Nelson Mandel African Institute of Science and Technology, Tanzania

Olatoye Isaac Ajadi,

University of KwaZulu-Natal, South Africa

Sam X Cheng,

 University of Florida, USA

Doshen Naidoo,

Private Mother and Child Hospital, South Africa

Huda Abbass Alhadi,

University of Khartoum, Sudan


With the grand success of Pediatric Conference 2018, Conference Series is proud to announce that the next series of "International Pediatrics, Infectious Diseases and Healthcare Conference” to be held during October 16-17, 2019 at Paris, France.

Let’s meet again @ Pediatrics 2019

For more information please visit:

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date October 16-17, 2019

Speaker Opportunity

Supported By

Pediatrics & Therapeutics Journal of Infectious Diseases & Therapy Cardiovascular Pharmacology Journal of Nursing & Care

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


  • Allergy In Children
  • Bacterial Infections
  • Bariatric Surgery
  • Best Paediatric Conferences
  • Best Pediatric Congress
  • Breastfeeding
  • Child Body Mass Index
  • Clinical Pediatrics
  • Common Infectious Diseases
  • Communicable Diseases
  • Complementary Therapy
  • Congenital Herpes Simplex Virus
  • Congenital Infections
  • Cytomegalo Virus
  • Enzyme Deficiencies In Children
  • Foot And Mouth Diseases
  • Fungal Infections
  • Global Nutrition
  • Healthcare In Children
  • Infections Of The Fetus
  • Infectious Diseases
  • Innovative Obesity
  • Keto Diet
  • Maternal Nutrition
  • Metabolic Disorders In Children
  • Microbial Infections
  • Mother And Childcare
  • Nanobots
  • Nanomedicine
  • Nanotechnology In Pediatrics
  • Neglected Tropical Diseases
  • Neonatal Infections
  • Neonatal Sepsis
  • Oncologic Researchers
  • Paediatric Nephrology
  • Peadiatricians
  • Pedaitric Nursing
  • Pediatric Cardiology
  • Pediatric Chemotherapy
  • Pediatric Congress
  • Pediatric Dentistry
  • Pediatric Dermatology
  • Pediatric Emergency Medicine
  • Pediatric Gastroenterology
  • Pediatric Healthcare
  • Pediatric Immunology
  • Pediatric Infectious Diseases
  • Pediatric Neurology
  • Pediatric Nurse
  • Pediatric Nutrition
  • Pediatric Obesity
  • Pediatric Oncology
  • Pediatric Oncology Nurses
  • Pediatric Ophthalmology
  • Pediatric Orthopaedics
  • Pediatric Pharmacology
  • Pediatric Physical Therapy
  • Pediatric Psychology
  • Pediatric Research
  • Pediatric Surgery
  • Pediatric Urology
  • Pediatric Yoga Therapy
  • Pediatrics
  • Perinatal HIV
  • Risk Factors Of Obesity
  • Top Pediatric Meet
  • Torch Infections In New Born
  • Tropical Diseases
  • World Pediatric Conferences
  • Yeast Infections